BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 36551144)

  • 1. On-Chip Organoid Formation to Study CXCR4/CXCL-12 Chemokine Microenvironment Responses for Renal Cancer Drug Testing.
    Ozcelik A; Abas BI; Erdogan O; Cevik E; Cevik O
    Biosensors (Basel); 2022 Dec; 12(12):. PubMed ID: 36551144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micro-Engineered Organoid-on-a-Chip Based on Mesenchymal Stromal Cells to Predict Immunotherapy Responses of HCC Patients.
    Zou Z; Lin Z; Wu C; Tan J; Zhang J; Peng Y; Zhang K; Li J; Wu M; Zhang Y
    Adv Sci (Weinh); 2023 Sep; 10(27):e2302640. PubMed ID: 37485650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform.
    Rajan SAP; Aleman J; Wan M; Pourhabibi Zarandi N; Nzou G; Murphy S; Bishop CE; Sadri-Ardekani H; Shupe T; Atala A; Hall AR; Skardal A
    Acta Biomater; 2020 Apr; 106():124-135. PubMed ID: 32068138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity.
    Jung DJ; Shin TH; Kim M; Sung CO; Jang SJ; Jeong GS
    Lab Chip; 2019 Sep; 19(17):2854-2865. PubMed ID: 31367720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank.
    Zhou Z; Cong L; Cong X
    Front Oncol; 2021; 11():762184. PubMed ID: 35036354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defined Alginate Hydrogels Support Spinal Cord Organoid Derivation, Maturation, and Modeling of Spinal Cord Diseases.
    Chooi WH; Ng CY; Ow V; Harley J; Ng W; Hor JH; Low KE; Malleret B; Xue K; Ng SY
    Adv Healthc Mater; 2023 Apr; 12(9):e2202342. PubMed ID: 36502337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
    Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
    Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in Microfluidic Technologies in Organoid Research.
    Liu H; Gan Z; Qin X; Wang Y; Qin J
    Adv Healthc Mater; 2023 Dec; ():e2302686. PubMed ID: 38134345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary Tumor Organoid Culture in Non-Adhesive Alginate for Luminal Mechanics and High-Throughput Drug Screening.
    Fang G; Lu H; Rodriguez de la Fuente L; Law AMK; Lin G; Jin D; Gallego-Ortega D
    Adv Sci (Weinh); 2021 Nov; 8(21):e2102418. PubMed ID: 34494727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organoid and Spheroid Tumor Models: Techniques and Applications.
    Gunti S; Hoke ATK; Vu KP; London NR
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recapitulation of First Pass Metabolism Using 3D Printed Microfluidic Chip and Organoid.
    Lee BE; Kim DK; Lee H; Yoon S; Park SH; Lee S; Yoo J
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-step synthesis of composite hydrogel capsules to support liver organoid generation from hiPSCs.
    Wang Y; Liu H; Zhang M; Wang H; Chen W; Qin J
    Biomater Sci; 2020 Oct; 8(19):5476-5488. PubMed ID: 32914807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidic droplet encapsulation-guided organoid growth promotes parental tumor phenotype recapitulation.
    Zhang W; Jin H; Lou S; Yang H; Dai X; Ma S
    Int J Cancer; 2024 Jan; 154(1):145-154. PubMed ID: 37622267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Microfluidic Organoid-on-a-Chip Platforms.
    Yu F; Hunziker W; Choudhury D
    Micromachines (Basel); 2019 Feb; 10(3):. PubMed ID: 30818801
    [No Abstract]   [Full Text] [Related]  

  • 15. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
    Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
    Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering Human Brain Assembloids by Microfluidics.
    Zhu Y; Zhang X; Sun L; Wang Y; Zhao Y
    Adv Mater; 2023 Apr; 35(14):e2210083. PubMed ID: 36634089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells.
    Choi JI; Jang SI; Hong J; Kim CH; Kwon SS; Park JS; Lim JB
    Cancer Lett; 2021 Feb; 498():42-53. PubMed ID: 33188841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering neurovascular organoids with 3D printed microfluidic chips.
    Salmon I; Grebenyuk S; Abdel Fattah AR; Rustandi G; Pilkington T; Verfaillie C; Ranga A
    Lab Chip; 2022 Apr; 22(8):1615-1629. PubMed ID: 35333271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Droplet Microfluidic System to Fabricate Hybrid Capsules Enabling Stem Cell Organoid Engineering.
    Liu H; Wang Y; Wang H; Zhao M; Tao T; Zhang X; Qin J
    Adv Sci (Weinh); 2020 Jun; 7(11):1903739. PubMed ID: 32537414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enabling peristalsis of human colon tumor organoids on microfluidic chips.
    Fang G; Lu H; Al-Nakashli R; Chapman R; Zhang Y; Ju LA; Lin G; Stenzel MH; Jin D
    Biofabrication; 2021 Oct; 14(1):. PubMed ID: 34638112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.